Pricing Log in Create free account

Greenwich LifeSciences, Inc. (GLSI) vs Q32 Bio Inc. (QTTB)

Greenwich LifeSciences, Inc. and Q32 Bio Inc. are both Biotechnology companies. Greenwich LifeSciences, Inc. and Q32 Bio Inc. are of similar size ($231.3M and $224.9M). Greenwich LifeSciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Q32 Bio Inc. trades at 2.5×. Across the 9 metrics below, Q32 Bio Inc. leads on 8 and Greenwich LifeSciences, Inc. on 1.

Valuation

Metric GLSI QTTB Biotechnology median
P/E n/m 2.49 8.50
P/S n/m n/m 9.71
P/B 68.25 1.44 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m (8.25) 9.21
Earnings yield (10.58%) 40.16% (33.15%)
Free cash flow yield (5.87%) (8.43%) (25.50%)

Profitability

Metric GLSI QTTB Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (986.31%) 72.14% (56.36%)
Return on assets (374.46%) 37.13% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GLSI QTTB Biotechnology median
Revenue growth (TTM) — (307.33%) 6.02%
EPS growth (last fiscal year) (18.18%) 148.96% 30.26%
Revenue growth, 5-year CAGR — 100.32% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GLSI QTTB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.54 20.30 4.72
Net debt to EBITDA 0.32 (2.21) 0.96

Dividend

Metric GLSI QTTB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GLSI QTTB Biotechnology median
Market cap 224.87m 231.31m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack